Treatment regimens in nAMD – do they really matter? This Cochrane review finds clinically insignificant differences https://t.co/geQGcB9sxm #ophthalmology #retina
RT @CochraneUK: Can anti‐vascular endothelial grown factor (anti‐VEGF) injections for neovascular age‐related macular degeneration (nAMD) b…
RT @CochraneLibrary: Can anti‐vascular endothelial grown factor (anti‐VEGF) injections for neovascular age‐related macular degeneration (nA…
RT @CochraneLibrary: Can anti‐vascular endothelial grown factor (anti‐VEGF) injections for neovascular age‐related macular degeneration (nA…
RT @CochraneLibrary: Can anti‐vascular endothelial grown factor (anti‐VEGF) injections for neovascular age‐related macular degeneration (nA…
Can anti‐vascular endothelial grown factor (anti‐VEGF) injections for neovascular age‐related macular degeneration (nAMD) be given less frequently than every month? @CochraneEyes systematic review includes 15 RCTs with 7732 participants: https://t.co/vYgJ
RT @Cochrane_US: Can anti‐vascular endothelial grown factor (anti‐VEGF) injections for neovascular age‐related macular degeneration (nAMD)…
Can anti‐vascular endothelial grown factor (anti‐VEGF) injections for neovascular age‐related macular degeneration (nAMD) be given less frequently than every month? @CochraneEyes systematic review includes 15 RCTs with 7732 participants: https://t.co/yO6B
RT @CochraneEyes: Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macul…
(1/3) Esta #RevisiónSistemática encontró q Pacientes q recibieron inyecciones mensuales tenían AV ligeramente mejor (1-2 letras; < 1/2 línea) al año en comparación con Pacientes q recibieron inyecciones “según sea necesario” (promedio: 7 inyecciones)..
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration (#AMD) https://t.co/Meb37TZRly https://t.co/vUGUy3GieG
💉 Ежемесячные интравитреальные инъекции при ВМД выглядят незначительно эффективнее режимов с редкими инъекциями, а вот риск эндофтальмита может возрастать вместе с частотой вмешательства https://t.co/1Rle5ByRH4
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration: https://t.co/yO6Byxvrhl Review from @CochraneEyes includes 15 RCTs with 7732 participants.
RT @felly500: Comparing different injection frequencies for neovascular age-related macular degeneration Cochrane review Important (If…
RT @EvidenceMatters: Please read the full thread. This falls into the "seems important to some but dull to everyone else"category until you…
Please read the full thread. This falls into the "seems important to some but dull to everyone else"category until you realise the cost-savings - and how the local money that is freed-up could be spent.
RT @felly500: Comparing different injection frequencies for neovascular age-related macular degeneration Cochrane review Important (If…
RT @felly500: Comparing different injection frequencies for neovascular age-related macular degeneration Cochrane review Important (If…
Comparing different injection frequencies for neovascular age-related macular degeneration Cochrane review Important (If you are into these kind of things) & remember the real world accuracy of VA measurement..... https://t.co/eO24miplcT